Bristol-Myers Squibb Company
Bristol-Myers Squibb Company scores highest on Nitro (85) and lowest on Price (50). Its PosiPenta is 67.05 out of 100, better than most similar companies.
On the Penta Grid this week, Bristol-Myers Squibb Company is Grid #35 of 837 in the Healthcare sector in United States, and Grid #120 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 67.05 | 50 | 73 | 85 | 53 | 74 |
| CVS Health Corporation | 69.38 | 61 | 88 | 80 | 49 | 69 |
| McKesson Corporation | 72.92 | 23 | 73 | 99 | 98 | 71 |
| Stryker Corporation | 63.30 | 36 | 82 | 64 | 57 | 78 |
| Vertex Pharmaceuticals Incorporated | 62.98 | 33 | 66 | 85 | 71 | 61 |
| Intuitive Surgical, Inc. | 58.62 | 18 | 72 | 68 | 88 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 13.16 |
| P/B ratio | 5.47 |
EEarnings
| Trailing EPS | ₹430.01 |
| Forward EPS | ₹626.30 |
NNitro
| Price | 5659.22 |
| 52-week high | 6501.23 |
| 52-week low | 4027.28 |
| Fall from 52-week high | 13.0% |
TTorque
| Return on equity (ROE) | 46.60% |
| Debt-to-equity | 2.02 |
AAnchor
| Beta (price swings) | 0.18 |
| Market cap | ₹11,56,016 Cr |
| Insider holding | 0.10% |
| Dividend yield | 4.16% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Bristol-Myers Squibb Company's PosiPenta score?
Bristol-Myers Squibb Company's PosiPenta is 67.05 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Bristol-Myers Squibb Company stand on the Penta Grid?
On the Penta Grid this week, Bristol-Myers Squibb Company is Grid #35 of 837 in the Healthcare sector in United States, and Grid #120 of 4,000 in United States.
Which PosiPenta pillar is strongest for Bristol-Myers Squibb Company?
Nitro (momentum), with a score of 85 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Bristol-Myers Squibb Company?
Price (valuation), with a score of 50 out of 100: around the middle of similar companies.
Has Bristol-Myers Squibb Company's PosiPenta changed since last week?
Yes, it rose 9.67 points, from 57.38 to 67.05.
PositoAI is for research and education only and is not investment advice.